In the article, “Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy” by Chen et al., published in the October issue (Can J Cardiol 2016;32:1221.e1-9), there are errors in the affiliations for Kuan-Hsuan Chen and Yueh Chien. The corrected affiliations are listed here.
Kuan-Hsuan Chen, RPh,a,b Yueh Chien, PhD,c,d Kang-Ling Wang, MD,e,f Hsin-Bang Leu, MD,a,f,g Chen-Yuan Hsiao, MD,h Ying-Hsiu Lai, PhD,d Chien-Ying Wang, MD,d,e Yuh-Lih Chang, PhD,c,d Shing-Jong Lin, MD,a,d,f Dau-Ming Niu, MD,a,i Shih-Hwa Chiou, MD,a,c,d and Wen-Chung Yu, MDe,f
aInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
bDepartment of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan
cInstitute of Pharmacology, National Yang-Ming University, Taipei, Taiwan
dDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan
eSchool of Medicine, National Yang-Ming University, Taipei, Taiwan
fDivison of Cardiology and Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
gHealth Care and Management Center, Taipei Veterans General Hospital, Taipei, Taiwan
hDepartment of Surgery, National Yang-Ming University Hospital, Taipei, Taiwan
iDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan
Article info
Identification
Copyright
© 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement TherapyCanadian Journal of CardiologyVol. 32Issue 10
- PreviewFabry disease (FD) causes progressive glycosphingolipid accumulation and damage in various organs, and several proinflammatory processes may be involved in this disease. Enzyme replacement therapy (ERT) can reduce the severity of Fabry cardiomyopathy (FC), but whether ERT could attenuate proinflammatory cytokines in FC remains unclear. In this study, we attempted to evaluate the efficacy of ERT on proinflammatory cytokines and vascular cell adhesion biomarkers.
- Full-Text
- Preview
